Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. Abbar M, Demattei C, El-Hage W, Llorca PM, et al. BMJ 2022;376:e067194.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abbar M, Demattei C, El-Hage W, Llorca PM, et al. Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial. BMJ 2022;376:e067194.
PMID: 35110300